431 related articles for article (PubMed ID: 35750466)
1. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
Thwaites PA; Gibson PR; Burgell RE
J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
[TBL] [Abstract][Full Text] [Related]
2. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
[TBL] [Abstract][Full Text] [Related]
3. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
Bennett SE; Walsh N; Moss T; Palmer S
Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
[TBL] [Abstract][Full Text] [Related]
4. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.
Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794
[TBL] [Abstract][Full Text] [Related]
5. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
Teran-Wodzinski P; Kumar A
Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
[TBL] [Abstract][Full Text] [Related]
7. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
Estrella E; Frazier PA
Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
[TBL] [Abstract][Full Text] [Related]
8. Anorectal manometry for the diagnosis of pelvic floor disorders in patients with hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome.
Zhou W; Zikos TA; Halawi H; Sheth VR; Gurland B; Nguyen LA; Neshatian L
BMC Gastroenterol; 2022 Dec; 22(1):538. PubMed ID: 36564719
[TBL] [Abstract][Full Text] [Related]
9. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
[TBL] [Abstract][Full Text] [Related]
10. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
Martin A
Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
[TBL] [Abstract][Full Text] [Related]
11. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
[TBL] [Abstract][Full Text] [Related]
12. Rectal hyposensitivity: a common pathophysiological finding in patients with constipation and associated hypermobile Ehlers-Danlos syndrome.
Choudhary A; Vollebregt PF; Aziz Q; Scott SM; Fikree A
Aliment Pharmacol Ther; 2022 Sep; 56(5):802-813. PubMed ID: 35758859
[TBL] [Abstract][Full Text] [Related]
13. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measures of tissue mechanics to detect hypermobile Ehlers-Danlos syndrome and hypermobility syndrome disorders: a systematic review.
Palmer S; Denner E; Riglar M; Scannell H; Webb S; Young G
Clin Rheumatol; 2020 Mar; 39(3):715-725. PubMed ID: 31955324
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of heavy shoulder strengthening exercise in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome and long-lasting shoulder complaints: study protocol for the Shoulder-MOBILEX study.
Liaghat B; Skou ST; Søndergaard J; Boyle E; Søgaard K; Juul-Kristensen B
Trials; 2020 Dec; 21(1):992. PubMed ID: 33261635
[TBL] [Abstract][Full Text] [Related]
16. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
[TBL] [Abstract][Full Text] [Related]
17. Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.
Garreth Brittain M; Flanagan S; Foreman L; Teran-Wodzinski P
Disabil Rehabil; 2024 May; 46(10):1936-1953. PubMed ID: 37231592
[TBL] [Abstract][Full Text] [Related]
18. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
[TBL] [Abstract][Full Text] [Related]
19. Mast cell activation and nutritional disorders in patients with hypermobility.
Penny HA; Aziz I; Lam C
Curr Opin Gastroenterol; 2024 May; 40(3):225-232. PubMed ID: 38393310
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]